BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Humanetics 

10400 Viking Drive
Suite 100
Eden Prairie  Minnesota  55344  U.S.A.
Phone: 952-937-7660 Fax: 952-937-7667


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Humanetics Enters Into Cooperative Research And Development Agreement With The U.S. Army Medical Research Institute of Chemical Defense 2/26/2014 9:04:25 AM    More...
Humanetics Awarded Patent Enabling Oral Administration of Powerful Radioprotectant 10/15/2013 10:13:33 AM    More...
Humanetics Awarded Contract With National Cancer Institute 10/3/2012 10:40:05 AM    More...
Humanetics Announces Alzheimer's Disease Patent Issuance 6/28/2012 9:54:05 AM    More...
Humanetics Awarded Exclusive Worldwide Licenses from Henry Ford Hospital Health System for Two Post-Exposure Medical Radiation Countermeasures 8/12/2010 10:04:02 AM    More...
Patent Issued for Humanetics' BIO 300 Radiation Countermeasure Drug 3/5/2010 8:51:40 AM    More...
Safety and Cognitive Stability Are Key Findings in Phase IIA Trial of New Alzheimer's Disease Treatment from Humanetics 7/13/2009 11:36:46 AM    More...
Humanetics Completes Phase I Safety and Pharmacokinetic Trial for New Radiation Countermeasure 1/11/2008 10:26:22 AM    More...
Humanetics Receives $3.8 Million from U.S. Department of Defense to Continue Development of Medical Radiation Countermeasures 11/16/2007 6:41:28 AM    More...
Humanetics Receives Orphan Drug Designation for Its BIO 300 Radiation Countermeasure 7/20/2007 11:08:24 AM    More...

//-->